Solara Active Pharma: US FDA inspects Vishakhapatnam facility of Solara Active Pharma

The US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences' API manufacturing facility in Visakhapatnam, Andhra Pradesh, with no observations. Solara confirms compliance with FDA standards. The facility, dedicated to Ibuprofen API production, marks Solara's second successful FDA inspection. The company aims for global market expansion with FDA-approved facilities.

Related Keywords

Puducherry ,Pondicherry ,India ,Visakhapatnam ,Andhra Pradesh ,Poorvank Purohit ,Solara Active Pharma Sciences Ltd ,Rd Centre ,National Stock Exchange ,Solara Active Pharma Sciences Limited ,Drug Administration ,Zero Form ,Active Pharma Sciences Limited ,Active Pharmaceutical Ingredient ,National Stock ,